Showing all 3 results

• 

  Bullous epidermolysis , Autoimmune enteropathy type I

  Granulocyte colony stimulating factor

  【Product name】Ji gran

  [English common name]G-CSF

  [Chinese common name]Granulocyte colony stimulating factor

  [English name]Granulocyte colony-stimulating factor

  [Chinese other name]You Baojin

  [indications]
  1. Cancer chemotherapy and other reasons lead toNeutropeniaCancer patients use myelosuppressive chemotherapy drugs, especially after strong bone marrow deprivation chemotherapy, injection of this product can help prevent the occurrence of neutropenia, reduce the degree of neutropenia, shorten the granulocyte The duration of the deficiency accelerates the recovery of granulocyte counts, thereby reducing the risk of fever associated with infection.
  2. Promote an increase in the number of neutrophils after bone marrow transplantation.
  3. Neutropenia caused by myelodysplastic syndrome,Aplastic anemiaCaused by neutropenia, congenital, idiopathic neutropenia,Myelodysplastic syndromeWith neutropenia, periodic neutropenia.

  [Usage and Dosage] The product is administered subcutaneously or intravenously 24 to 48 hours after the end of the chemotherapy drug administration, once a day. The dosage and time of administration of this product should be determined according to the intensity of chemotherapy and the degree of neutrophil decline. For patients with greater chemotherapy intensity or decreased granulocyte count, it is more suitable to continue to take the drug for more than 7 days at a dose of 2.5 μg/kg body weight/day until the neutrophil is restored to 5000/mm3; if the dose of chemotherapy drug is used Lower, estimated to cause less severe myelosuppression, consider using a lower dose to prevent neutropenia, 1.25μg / kg body weight / day dose to the neutrophil number is stable in a safe range, Patients with significantly reduced neutrophils after chemotherapy (neutrophil count <1000/mm3).

  [Storage]2～8°C away from light,Sealed and stored.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Lymphangiomyomatosis , scleroderma

  Sirolimus

  【Product name】RAPAMUNE

  [English common name]Sirolimus

  [Chinese common name]Sirolimus

  [English name]Rapamycin, Antibiotic AY 22989

  [Chinese other name]Rapamycin, antibiotic

  [indications]
  Sirolimus capsule: It can be used for the treatment of organ transplant anti-rejection and autoimmune diseases.
  Sirolimus: Rapamune is suitable for patients undergoing kidney transplantation to prevent organ rejection. It is recommended that Rapamune be used in combination with cyclosporine and corticosteroids.
  Oral solution of sirolimus: suitable for patients undergoing kidney transplantation to prevent organ rejection.

  【Dosage】
  Sirolimus capsules: Oral. A single loading dose of 6 mg followed by a maintenance dose of 2 mg/day.
  Sirolimus: Rapamo is intended for use by immunotherapists and physicians who have experience in treating kidney transplant patients. Patients receiving this drug should be treated in an institution equipped with appropriate laboratories and ancillary medical facilities and personnel. The physician responsible for maintaining the treatment should have complete information necessary for patient follow-up. It is recommended that rapazone tablets be used in combination with cyclosporine and corticosteroids. Repa is used orally, once a day, with or without food. Since the bioavailability of tablets after crushing, chewing or incision has not been determined, such a method of use is not recommended. Oral solutions should be prescribed for patients who cannot take tablets and instructions should be used. Rapai should be taken as soon as possible after transplantation. It is recommended that the use of Repaming should be taken with cyclosporine oral solution (modified) and / or cyclosporine capsule (modified).
  Oral solution of sirolimus: It is recommended that the oral solution of sirolimus be combined with cyclosporine and corticosteroids. On the first day, the single dose of 6mg was loaded, 2mg/day in 2 weeks (reduced adverse reactions), and 1-2mg/day after 2 weeks. In order to minimize the difference in absorption of the drug, the drug should be taken with or without food. Grapefruit juice can slow the metabolism of sirolimus regulated by CYP3A4 and therefore cannot be used to deliver or dilute the oral solution of sirolimus. It is recommended to take sirolimus 4 hours after taking cyclosporine oral solution (microemulsion) and/or cyclosporine capsule (microemulsion). The starting dose of patients with a dose-adjusted age of 13 years or older but weighing less than 40 kg should be adjusted according to the body surface area at 1 mg/m2/day, and the dose should be 3 mg/m2.

  [Storage]
  Sirolimus capsule: sealed, moisture-proof.
  Sirolimus tablets: shading, confined preservation.
  Sirolimus oral solution: sealed.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Multiple myeloma , scleroderma

  Rituximab

  【Product name】Rituxan

  [English common name]Rituximab

  [Chinese common name]Rituximab

  [English name]

  [Chinese other name]

  [Indications] This product is suitable for: recurrent or drug-resistant follicular central lymphoma (international work classification B, C and D subtype B cell non-Hodgkin's lymphoma)Treatment. Previously untreated CD20-positive stage III-IV follicular non-Hodgkin's lymphoma, patients should be treated with standard CVP chemotherapy (Cyclophosphamide,VincristineAnd prednisone) 8 cycles of combined treatment. CD20-positive diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) should be treated in combination with standard CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone) for 8 cycles.

  [Usage and Dosage] Usage and Usage Instructions Under the sterile conditions, the required dose of rituximab is taken and placed in a sterile non-pyrogenic infusion bag containing 0.9% saline or 5% dextrose solution. The concentration of rituximab was 1 mg/ml. Gently invert the injection bag to mix the solution and avoid foaming. As this product does not contain antimicrobial preservatives or bacteriostatic preparations, aseptic technique must be checked. The injection should be observed for particles or discoloration before intravenous use. Rituximab is diluted and administered intravenously through a dedicated infusion tube for the treatment of patients in ambulatory bed. The treatment of rituximab should be performed in a ward with complete resuscitation equipment and under the direct supervision of an experienced oncologist or hematologist. Monitor patients with respiratory symptoms or hypotension for at least 24 hours.

  [Storage] Sealed.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.